Health and Healthcare
5864 Articles
MedImmune, Inc. (MEDI-NASDAQ) announced that its board of directors has authorized management to evaluate whether third parties would have an…
by H.S. AyoubBioHealth Investor.com
by H.S. AyoubBioHealthInvestor.com
Genetech (DNA-NYSE) posted earnings: $0.74 EPS and revenues were $2.843 Billion; expectations were $0.67 EPS & R$2.74 Billion. The stock…
Cell Genesys, Inc. (CEGE-NASDAQ) has done what many small biotechs do that are in need of cash: sell shares in…
Dendreon (DNDN-NASDAQ) is trading down more than 4% at $21.25 in early trading after JMP Securities downgraded the shares. DNDN…
Amgen (AMGN-NASDAQ) is naming a new CFO. Robert Bradway is replacing Richard Nanula, who is leaving to pursue other opportunities. …
Adolor Corp. (ADLR-NASDAQ) may have just joined the ranks of current and future biotech zombies. The company suspended its lead…
From BioHealth Investor
by H.S. AyoubBioHealth Investor.com Biotechnology GENETIC TECH SPON [GENE] +48.22% DENDREON CORP [DNDN] +19.69% CORCEPT THERAPEUTICS [CORT] +15.70% ANTIGENICS INC…
by H.S. AyoubBioHealth Investor.com Biotechnology IDM PHARMA INC [IDMI] +45.33% NANOGEN INC [NGEN] +30.95% ENCYSIVE PHARMA [ENCY] +14.89% CARDIOVASCULAR BIOTH…
Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon…
Our top personal finance-related articles today. Your wallet will thank you later.